AGP Picks
View all

St. Vincent & Grenadines Health Press
Provided by AGP

St. Vincent & Grenadines Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Health Press.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on July 31, 2026

Achieve Life Sciences Announced Granting of New Hire Inducement Awards
10 hours ago

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

Indeterminate GlobeNewswire
Cerenome Launches as an Integrated CNS Oncology Company
10 hours ago

Cerenome Launches as an Integrated CNS Oncology Company

Indeterminate GlobeNewswire
SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics
10 hours ago

SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics

Indeterminate GlobeNewswire
IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
10 hours ago

IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients
11 hours ago

Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients

Indeterminate GlobeNewswire
Jushi Holdings Inc. Completes Redomicile from British Columbia to Nevada
11 hours ago

Jushi Holdings Inc. Completes Redomicile from British Columbia to Nevada

Indeterminate GlobeNewswire
Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
11 hours ago

Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026

Indeterminate GlobeNewswire
Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026
11 hours ago

Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026

Indeterminate GlobeNewswire
J-Star Holding Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement
11 hours ago

J-Star Holding Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement

Indeterminate GlobeNewswire
Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis
11 hours ago

Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis

Indeterminate GlobeNewswire
Ocugen to Participate in Upcoming August Investor Conferences
12 hours ago

Ocugen to Participate in Upcoming August Investor Conferences

Indeterminate GlobeNewswire
Radiopharm Theranostics Reports Business Update
12 hours ago

Radiopharm Theranostics Reports Business Update

Indeterminate GlobeNewswire
INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th
12 hours ago

INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th

Indeterminate GlobeNewswire
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
12 hours ago

Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
12 hours ago

Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates

Indeterminate GlobeNewswire
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
12 hours ago

INmune Bio Receives R&D Rebates of Approximately $4.6 Million

Indeterminate GlobeNewswire
Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation
12 hours ago

Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation

Indeterminate GlobeNewswire
Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab
12 hours ago

Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab

Indeterminate GlobeNewswire
Vireo Growth Inc. Announces a Four-Deal Transaction to Establish Presence in Ohio
12 hours ago

Vireo Growth Inc. Announces a Four-Deal Transaction to Establish Presence in Ohio

Indeterminate GlobeNewswire
Italfarmaco Announces Managed Entry Agreement in Georgia for Givinostat as Treatment for Patients with Duchenne Muscular Dystrophy
12 hours ago

Italfarmaco Announces Managed Entry Agreement in Georgia for Givinostat as Treatment for Patients with Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

St. Vincent & Grenadines Health Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.